Scherr DS - Search Results

1

Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.

Green DA, Rink M, Hansen J, Cha EK, Robinson B, Tian Z, Chun FK, Tagawa S, Karakiewicz PI, Fisch M, Scherr DS, Shariat SF. Green DA, et al. Among authors: scherr ds. BJU Int. 2013 Mar;111(3):404-11. doi: 10.1111/j.1464-410X.2012.11370.x. Epub 2012 Jul 13. BJU Int. 2013. PMID: 22805163

2

Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.

Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS. Boorjian S, et al. Among authors: scherr ds. Urology. 2004 Aug;64(2):383-8. doi: 10.1016/j.urology.2004.03.025. Urology. 2004. PMID: 15302512

3

Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.

Raman JD, Ng CK, Boorjian SA, Vaughan ED Jr, Sosa RE, Scherr DS. Raman JD, et al. Among authors: scherr ds. BJU Int. 2005 Nov;96(7):1031-5. doi: 10.1111/j.1464-410X.2005.05804.x. BJU Int. 2005. PMID: 16225523

4

A population-based study of renal cell carcinoma and prostate cancer in the same patients.

Barocas DA, Rabbani F, Scherr DS, Vaughan ED Jr. Barocas DA, et al. Among authors: scherr ds. BJU Int. 2006 Jan;97(1):33-6. doi: 10.1111/j.1464-410X.2005.05880.x. BJU Int. 2006. PMID: 16336324

5

Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen.

Barocas DA, Mathew S, DelPizzo JJ, Vaughan ED Jr, Sosa RE, Fine RG, Akhtar M, Scherr DS. Barocas DA, et al. Among authors: scherr ds. BJU Int. 2007 Feb;99(2):290-5. doi: 10.1111/j.1464-410X.2006.06607.x. Epub 2006 Dec 1. BJU Int. 2007. PMID: 17092279

6

Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.

Raman JD, Sosa RE, Vaughan ED Jr, Scherr DS. Raman JD, et al. Among authors: scherr ds. Urology. 2007 Feb;69(2):251-4. doi: 10.1016/j.urology.2006.09.065. Urology. 2007. PMID: 17320658

7

Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.

Smith EB, Schwartz M, Kawamoto H, You X, Hwang D, Liu H, Scherr DS. Smith EB, et al. Among authors: scherr ds. J Urol. 2007 Jun;177(6):2347-51. doi: 10.1016/j.juro.2007.01.112. J Urol. 2007. PMID: 17509356

8

Management of patients with upper urinary tract transitional cell carcinoma.

Raman JD, Scherr DS. Raman JD, et al. Among authors: scherr ds. Nat Clin Pract Urol. 2007 Aug;4(8):432-43. doi: 10.1038/ncpuro0875. Nat Clin Pract Urol. 2007. PMID: 17673914 Review.

9

Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy.

Wang GJ, Barocas DA, Raman JD, Scherr DS. Wang GJ, et al. Among authors: scherr ds. BJU Int. 2008 Jan;101(1):89-93. doi: 10.1111/j.1464-410X.2007.07212.x. Epub 2007 Sep 20. BJU Int. 2008. PMID: 17888044

10

Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.

Liu H, Schwartz MJ, Hwang DH, Scherr DS. Liu H, et al. Among authors: scherr ds. BJU Int. 2008 Apr;101(7):894-901. doi: 10.1111/j.1464-410X.2008.07459.x. Epub 2008 Jan 30. BJU Int. 2008. PMID: 18241249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters